Cochrane Review Group
Pregnancy and Childbirth
252 systematic reviews in Pregnancy and Childbirth ask 3,601 questions. 20.2% have no studies to answer them, 23% rest on very low certainty evidence and 17.6% reach moderate or high certainty.
Reviews
252
Questions
3,601
current versions
No studies
20.2%
Moderate or high
17.6%
No studies 726 · 20.2%Ungraded 421 · 11.7%Very low 828 · 23%Low 993 · 27.6%Moderate 486 · 13.5%High 147 · 4.1%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Thinnest evidence
All no studies and very low questions| Question | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Magnesium sulphate vs placebo (outcomes Major neurodevelopmental disability (school age)** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | RR 0.92 [0.53, 1.62] | 2 studies · 940 participants | Very low |
Magnesium sulphate vs placebo (outcomes Breastfeeding at hospital discharge** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | no estimate extracted | NR | No studies |
Magnesium sulphate vs placebo (outcomes Women’s views of treatment** · women at risk of preterm birth (< 34 weeks' gestation) Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus (2024) · Cochrane | no estimate extracted | NR | No studies |
Summary of findings table ‐ Midwife continuity models vs other models of care Third or fourth degree tear · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.1 [0.81, 1.49] | 7 studies · 9437 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Maternal readmission within 28 days · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.52 [0.78, 2.96] | 1 study · 1195 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Attendance at birth by known midwife · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 9.13 [5.87, 14.21] | 11 studies · 9273 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Apgar score less than or equal to 7 at 5 minutes · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.95 [0.72, 1.24] | 13 studies · 12806 participants | Very low |
Summary of findings table ‐ Midwife continuity models vs other models of care Fetal loss before 24 weeks gestation · childbearing women and their infants (all) (important/secondary outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.82 [0.67, 1.01] | 12 studies · 15913 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Regional analgesia (epidural/spinal) · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.85 [0.79, 0.92] | 15 studies · 17754 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Fetal loss at or after 24 weeks gestation · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 1.24 [0.73, 2.13] | 12 studies · 16122 participants | Very low |
Summary of findings table ‐ Midwife continuity of care models vs other models of care Neonatal death (baby born alive at any gestation and dies within 28 days) · childbearing women and their infants (all) (critical outcomes) Midwife continuity of care models versus other models of care for childbearing women (2024) · Cochrane | RR 0.85 [0.43, 1.71] | 10 studies · 14718 participants | Very low |
Summary of findings table ‐ Vitamin B12 supplementation vs placebo/no vitamin B12 supplementation Maternal anaemia · pregnant women Vitamin B12 supplementation during pregnancy for maternal and child health outcomes (2024) · Cochrane | RR 1.08 [0.93, 1.26] | 2 studies · 284 participants | Very low |
Reviews 252
Magnesium sulphate for women at risk of preterm birth for neuroprotection of the fetus
CochraneSoF table
18 questions
Midwife continuity of care models versus other models of care for childbearing women
CochraneSoF table
26 questions
Vitamin B12 supplementation during pregnancy for maternal and child health outcomes
CochraneSoF table
7 questions
Psychosocial and medication interventions to stop or reduce alcohol consumption during pregnancy
CochraneSoF table
5 questions
Respiratory syncytial virus vaccination during pregnancy for improving infant outcomes
CochraneSoF table
8 questions
Planned hospital birth compared with planned home birth for pregnant women at low risk of complications
CochraneSoF table
7 questions
Induction of labour at or near term for suspected fetal macrosomia
CochraneSoF table
7 questions
Mechanical methods for induction of labour
CochraneSoF table
21 questions
Cephalic version by moxibustion for breech presentation
CochraneSoF table
14 questions
Alternative magnesium sulphate regimens for women with pre‐eclampsia and eclampsia
CochraneSoF table
61 questions
Antenatal dietary supplementation with myo‐inositol for preventing gestational diabetes
CochraneSoF table
14 questions
Different intensities of glycaemic control for women with gestational diabetes mellitus
CochraneSoF table
14 questions
Fetal scalp stimulation for assessing fetal well‐being during labour
CochraneSoF table
14 questions
Interventions affecting the nitric oxide pathway versus placebo or no therapy for fetal growth restriction in pregnancy
CochraneSoF table
12 questions
Support for healthy breastfeeding mothers with healthy term babies
CochraneSoF table
20 questions
Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes
CochraneSoF table
22 questions
Different corticosteroids and regimens for accelerating fetal lung maturation for babies at risk of preterm birth
CochraneSoF table
30 questions
Routine vaginal examinations compared to other methods for assessing progress of labour to improve outcomes for women and babies at term
CochraneSoF table
28 questions
Perioperative pharmacological interventions for fetal immobilisation during fetal surgery and invasive procedures
CochraneSoF table
7 questions
Cervical pessary for preventing preterm birth in singleton pregnancies
CochraneSoF table
21 questions
Maternal postures for fetal malposition in labour for improving the health of mothers and their infants
CochraneSoF table
28 questions
Zinc supplementation for improving pregnancy and infant outcome
CochraneSoF table
7 questions
Umbilical vein injection for management of retained placenta
CochraneSoF table
28 questions
Venous thromboembolism prophylaxis for women at risk during pregnancy and the early postnatal period
CochraneSoF table
30 questions
Early postnatal discharge from hospital for healthy mothers and term infants
CochraneSoF table
10 questions